Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?

BMC medical genetics - 14 Jul 2010

Kudzi William, Dodoo Alexander N O, Mills Jeremy J

Abstract excerpt

BACKGROUND: Ivermectin, a substrate of multidrug resistance (MDR1) gene and cytochrome P450 (CYP) 3A4, has been used successfully in the treatment of onchocerciasis in Ghana. However, there have been reports of suboptimal response in some patients after repeated treatment. Polymorphisms in host MDR1 and CYP3A genes may explain the observed suboptimal response to ivermectin. We genotyped relevant functional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP3A

Share to Drug Resistance, Multiple

Share to Ivermectin

Share to Polymorphism, Restriction Fragment Length

Source

Open in PubMed Open full text

Identifiers

PMID: 20630055
DOI: 10.1186/1471-2350-11-111
PMCID: PMC3161347

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?PMID 20630055Read ↗

Plasmodium falciparum genetic factors rather than host factors are likely to drive resistance to ACT in GhanaSemantic proximity Read ↗

Plasmodium falciparum genetic factors rather than the hosts' are likely to drive resistance to acts in ghana.Semantic proximity Read ↗

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global PharmacogeneticsSemantic proximity Read ↗

Lack of an effect of CYP3A4 and MDR1 gene polymorphisms on colchicine pharmacogenetics in the treatment of Familial Mediterranean fever.Semantic proximity Read ↗

Therapeutic implications of the MDR‐1 geneSemantic proximity Read ↗

Identifying sub-optimal responses to ivermectin in the treatment of River BlindnessSemantic proximity Read ↗

Identification of variant ABC-transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa.Semantic proximity Read ↗

Reduced genetic variation of an Onchocerca volvulus ABC transporter gene following treatment with ivermectin.Semantic proximity Read ↗

The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome.Semantic proximity Read ↗

Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.Semantic proximity Read ↗

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.Semantic proximity Read ↗

P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.